4-chloro-n-(2-morpholin-4-ylethyl)-2-prop-2-enoxybenzamide (CED0253868)

Record Information
Version1.0
Creation Date2026-08-28 19:44:09 UTC
Update Date2026-08-28 19:44:09 UTC
SynCED IDCED0253868
Secondary Accession Numbers
  • CHEM298545
Identification
Common Name4-chloro-n-(2-morpholin-4-ylethyl)-2-prop-2-enoxybenzamide
ClassSmall Molecule
Description
4-chloro-n-(2-morpholin-4-ylethyl)-2-prop-2-enoxybenzamide belongs to the benzoic acids and derivatives, a subclass of benzene and substituted derivatives within the organic compounds. This benzenoid compound has the chemical formula C16H21ClN2O3 and an average molecular weight of 324.80 g/mol.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC16H21ClN2O3
Average Molecular MassNot Available
Monoisotopic Mass324.124 g/mol
CAS Registry Number28046-03-9
IUPAC NameNot Available
Traditional NameNot Available
SMILESC=CCOC1=C(C=CC(=C1)Cl)C(=O)NCCN2CCOCC2
InChI IdentifierInChI=1S/C16H21ClN2O3/c1-2-9-22-15-12-13(17)3-4-14(15)16(20)18-5-6-19-7-10-21-11-8-19/h2-4,12H,1,5-11H2,(H,18,20)
InChI KeyNEHGSNUYCSUDMZ-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
159.0 Log mg/kg [90:280]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
Exposure Sources
Source IDSourceSectorReference
CEDs000524Hybrid Capacitors?Hybrid capacitors are energy storage devices that combine the properties of electrolytic and supercapacitors, utilizing a combination of electrochemical principles to achieve higher energy density and power density.Electrical & Electronic EquipmentPubChem
CEDs000629Swings?Swings, commonly found in playgrounds and recreational areas, are often constructed using synthetic materials such as plastics and rubber composites.Recreation & sports surfacesPubChem
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
CEDs000740Paper?Paper production involves the processing of wood fibers and the use of various chemicals, which can lead to synthetic chemical contamination.Paper, pulp & fiber productsPubChem
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
B-cell lymphoma 3 protein structureClick to view 3D structureB-cell lymphoma 3 proteinP20749HumansPredicted (SEA)
Prediction Confidence Score
0.431
Applicability Domain
0.431
Statistical Significance
1.00e-04
Supporting Reference Compounds
1
E-value
0.778492
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)
Prediction Confidence Score
0.36
Applicability Domain
0.556
Statistical Significance
0.0223
Supporting Reference Compounds
562
E-value
173.837
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)
Prediction Confidence Score
0.357
Applicability Domain
0.556
Statistical Significance
0.0284
Supporting Reference Compounds
953
E-value
221.325
Click to view 3D structure5-hydroxytryptamine receptor 1AP19327Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.353
Applicability Domain
0.386
Statistical Significance
0.0224
Supporting Reference Compounds
541
E-value
174.071
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)
Prediction Confidence Score
0.351
Applicability Domain
0.386
Statistical Significance
0.0388
Supporting Reference Compounds
1103
E-value
302.133
Amine oxidase [flavin-containing] B structureClick to view 3D structureAmine oxidase [flavin-containing] BP27338HumansPredicted (SEA)
Prediction Confidence Score
0.34
Applicability Domain
0.556
Statistical Significance
0.0158
Supporting Reference Compounds
315
E-value
123.235
D(4) dopamine receptor structureClick to view 3D structureD(4) dopamine receptorP21917HumansPredicted (SEA)
Prediction Confidence Score
0.337
Applicability Domain
0.386
Statistical Significance
0.0281
Supporting Reference Compounds
524
E-value
218.601
Click to view 3D structureD(3) dopamine receptorP19020Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.331
Applicability Domain
0.386
Statistical Significance
0.0136
Supporting Reference Compounds
145
E-value
105.641
Click to view 3D structureTumor necrosis factor receptor superfamily member 16Q9Z0W1Mus musculusPredicted (SEA)
Prediction Confidence Score
0.328
Applicability Domain
0.328
Statistical Significance
2.00e-04
Supporting Reference Compounds
1
E-value
1.55698
Click to view 3D structureD(2) dopamine receptorP61169RatPredicted (SEA)
Prediction Confidence Score
0.328
Applicability Domain
0.365
Statistical Significance
0.0338
Supporting Reference Compounds
528
E-value
263.442
Click to view 3D structureSigma intracellular receptor 2Q5BJF2HumansPredicted (SEA)
Prediction Confidence Score
0.327
Applicability Domain
0.556
Statistical Significance
0.0186
Supporting Reference Compounds
308
E-value
144.644
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP14842Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.326
Applicability Domain
0.385
Statistical Significance
0.0246
Supporting Reference Compounds
380
E-value
191.353
Plasma membrane ATPase 1 structureClick to view 3D structurePlasma membrane ATPase 1P05030Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)Predicted (SEA)
Prediction Confidence Score
0.323
Applicability Domain
0.323
Statistical Significance
2.30e-04
Supporting Reference Compounds
1
E-value
1.79053
Mast/stem cell growth factor receptor Kit structureClick to view 3D structureMast/stem cell growth factor receptor KitP10721HumansPredicted (SEA)
Prediction Confidence Score
0.322
Applicability Domain
0.353
Statistical Significance
0.0677
Supporting Reference Compounds
905
E-value
527.039
Proto-oncogene tyrosine-protein kinase Src structureClick to view 3D structureProto-oncogene tyrosine-protein kinase SrcP12931HumansPredicted (SEA)
Prediction Confidence Score
0.322
Applicability Domain
0.341
Statistical Significance
0.0786
Supporting Reference Compounds
1158
E-value
611.895
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP08909RatPredicted (SEA)
Prediction Confidence Score
0.321
Applicability Domain
0.385
Statistical Significance
0.0166
Supporting Reference Compounds
185
E-value
129.074
Voltage-gated inwardly rectifying potassium channel KCNH2 structureClick to view 3D structureVoltage-gated inwardly rectifying potassium channel KCNH2Q12809HumansPredicted (SEA)
Prediction Confidence Score
0.321
Applicability Domain
0.364
Statistical Significance
0.1074
Supporting Reference Compounds
1498
E-value
836.101
Mitogen-activated protein kinase 14 structureClick to view 3D structureMitogen-activated protein kinase 14Q16539HumansPredicted (SEA)
Prediction Confidence Score
0.32
Applicability Domain
0.341
Statistical Significance
0.0554
Supporting Reference Compounds
668
E-value
431.518
Epidermal growth factor receptor structureClick to view 3D structureEpidermal growth factor receptorP00533HumansPredicted (SEA)
Prediction Confidence Score
0.318
Applicability Domain
0.341
Statistical Significance
0.093
Supporting Reference Compounds
1301
E-value
724.076
Click to view 3D structureD(4) dopamine receptorP30729Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.318
Applicability Domain
0.386
Statistical Significance
0.0117
Supporting Reference Compounds
92
E-value
91.2393
D(3) dopamine receptor structureClick to view 3D structureD(3) dopamine receptorP35462HumansPredicted (SEA)
Prediction Confidence Score
0.31
Applicability Domain
0.32
Statistical Significance
0.0576
Supporting Reference Compounds
861
E-value
448.723
Mitogen-activated protein kinase 8 structureClick to view 3D structureMitogen-activated protein kinase 8P45983HumansPredicted (SEA)
Prediction Confidence Score
0.307
Applicability Domain
0.353
Statistical Significance
0.0821
Supporting Reference Compounds
782
E-value
639.298
Glycogen synthase kinase-3 alpha structureClick to view 3D structureGlycogen synthase kinase-3 alphaP49840HumansPredicted (SEA)
Prediction Confidence Score
0.306
Applicability Domain
0.341
Statistical Significance
0.0807
Supporting Reference Compounds
754
E-value
628.243
Hepatocyte growth factor receptor structureClick to view 3D structureHepatocyte growth factor receptorP08581HumansPredicted (SEA)
Prediction Confidence Score
0.306
Applicability Domain
0.341
Statistical Significance
0.0891
Supporting Reference Compounds
934
E-value
693.559
Receptor tyrosine-protein kinase erbB-2 structureClick to view 3D structureReceptor tyrosine-protein kinase erbB-2P04626HumansPredicted (SEA)
Prediction Confidence Score
0.306
Applicability Domain
0.341
Statistical Significance
0.0748
Supporting Reference Compounds
674
E-value
582.234
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available